Search

2 results

Technology Assessment of the Dutch Lung Transplantation Program
Petra J. Van Enckevort, Elisabeth M. Tenvergert, Gouke J. Bonsel, Albert Geertsma, Wim Van Der Bij, Wim J. De Boer, Marc A. Koopmanschap, Maiwenn J. Al, Frans F.h. Ruttten
Journal: International Journal of Technology Assessment in Health Care / Volume 14 / Issue 2 / Spring 1998
Published online by Cambridge University Press: 10 March 2009, pp. 344-356
Print publication: Spring 1998
- Article
- Export citation
View abstract

The costs, effects, and cost-effectiveness of the Dutch Lung Transplantation program were assessed. The results show that lung transplantation is a very costly intervention that improves survival and quality of life. Costs per life-year and per QALY gained were, respectively, US $90,000 and US $71,000.

Cost-utility of brief psychological treatment for depression and anxiety
Leona Hakkaart-Van Roijen, Annemieke Van Straten, Maiwenn Al, Frans Rutten, Marianne Donker
Journal: The British Journal of Psychiatry / Volume 188 / Issue 4 / April 2006
Published online by Cambridge University Press: 02 January 2018, pp. 323-329
Print publication: April 2006
- Article
- PDF
- HTML
- Export citation
View abstract

Background
The cost-utility of brief therapy compared with cognitive–behavioural therapy (CBT) and care as usual in the treatment of depression and anxiety has not yet been determined.

Aims
To assess the cost-utility of brief therapy compared with CBT and care as usual.

Method
A pragmatic randomised controlled trial involving 702 patients was conducted at 7 Dutch mental healthcare centres (MHCs). Patients were interviewed at baseline and then every 3 months over a period of 1.5 years, during which time data were collected on direct costs, indirect costs and quality of life.

Results
The mean direct costs of treatment at the MHCs were significantly lower for brief therapy than for CBT and care as usual. However, after factoring in other healthcare costs and indirect costs, no significant differences between the treatment groups could be detected. We found no significant differences in quality-adjusted life-years between the groups.

Conclusions
Cost-utility did not differ significantly between the three treatment groups.